IGC Pharma - IGC Net earnings per share for the last four quarters

Official company branding of IGC Pharma Inc (IGC)

IGC Pharma, Inc. (IGC) is recruiting leading neurobiologists to develop Alzheimer's disease therapies supported by stable funding. This chart from the GURU.Markets terminal illustrates profit dynamics via the EPS YoY TTM shift, while the -2.90 value captures the metric level. IGC Pharma, Inc. (IGC) is combining AI and cannabinoids to create safe alternatives to psychotropic drugs. Current clinical trials are acting as catalysts, while the market price already prices in pipeline risks.

Net earnings per share (EPS TTM): IGC Pharma (IGC) for 02/11/2024 - 11/18/2026

IGC (IGC Pharma, Inc.): analytical breakdowns and indicator data

- market value and analyst target forecast:
Fundamental company valuation:India Globalization Capital IGC
Product sample of IGC Pharma Inc

IGC Pharma, Inc. (IGC) focuses on high-risk clinical trials of cannabinoids for the therapy of Alzheimer's disease. By analyzing the current state of annual EPS TTM growth, an investor gains daily monitoring of trailing twelve-month profit dynamics, allowing for the immediate detection of consensus deviations and an exit from the asset before a deep correction, while critically assessing the fundamental stability of the business.

Competitor analysis for IGC Pharma, Inc.

Earnings per share for the trailing year INDV (Indivior plc)|Collegium Corp (COLL) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Cronos|CGC (Canopy Growth Corp.) - Net earnings per share (EPS TTM)|HITI: Earnings per share for the trailing year|Earnings per share for the last twelve months Aurora Cannabis, Inc. (ACB)|Net earnings per share for the last 12 months Achieve Life Sciences, Inc. ACHV|skyebioscience.com - Net earnings per share for the last 12 months|Anebulo (ANEB) - Net earnings per one share for the last twelve months|Canndoc - Net earnings per share (EPS TTM)|Earnings per share for the trailing year NTRB (nutriband.com)|Nasus Pharma Ltd (NSRX) - Earnings per share for the last twelve months|MIRA Pharma - Earnings per share for the trailing year|Net earnings per share for the last 12 months FLGC|Earnings per share for the last 12 months IMCC (imcannabis.com)|Earnings per share for the last twelve months adialpharma.com (ADIL)|ARTL (Artelo Biosciences, Inc.) - Earnings per share for the trailing year|Ensysce Biosciences - Net earnings per share for the last 12 months|Earnings per share for the trailing year TTNP|gnln.com - Net earnings per share (EPS TTM)|Earnings per share for the trailing year INM (InMed)|Akanda Corp. (AKAN) - Earnings per share for the last twelve months|ENVB - Net earnings per share for the last four quarters|BGXX (Bright Green Corp.) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Hempacco Co., Inc. HPCO